BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37929565)

  • 1. Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease.
    Bawaskar P; Thomas N; Ismail K; Guo Y; Chhikara S; Athwal PSS; Ranum A; Jadhav A; Hooker Mendez A; Nadkarni I; Frerichs D; Velangi P; Ergando T; Akram H; Kanda A; Shenoy C
    Circulation; 2024 Mar; 149(11):807-821. PubMed ID: 37929565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
    Corbalan R; Bassand JP; Illingworth L; Ambrosio G; Camm AJ; Fitzmaurice DA; Fox KAA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Kakkar AK;
    JAMA Cardiol; 2019 Jun; 4(6):526-548. PubMed ID: 31066873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation.
    Guddeti RR; Matsuo Y; Matsuzawa Y; Aoki T; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25095871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance.
    Wang TKM; Kocyigit D; Choi H; Anthony CM; Chan N; Bullen J; Popović ZB; Kapadia SR; Krishnaswamy A; Griffin BP; Flamm SD; Tang WHW; Kwon DH
    Circ Cardiovasc Imaging; 2023 Aug; 16(8):e015134. PubMed ID: 37503633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Individual Patient-Level Meta-Analysis of Ischemic Versus Nonischemic Cardiomyopathy and Trajectory of Decongestion in Patients With Acute Decompensated Heart Failure.
    Akhtar KH; Maqsood MH; Ansari SA; Siddiqi TJ; Arshad MS; Greene SJ; Butler J; Khan MS
    Am J Cardiol; 2023 Aug; 200():32-39. PubMed ID: 37295177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of Nonobstructive Coronary Artery Disease in the Prognosis of Patients With Heart Failure.
    Braga JR; Austin PC; Ross HJ; Tu JV; Lee DS
    JACC Heart Fail; 2019 Jun; 7(6):493-501. PubMed ID: 31078476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Clustered Ventricular Arrhythmia and Cycle Length With Scar Burden in Cardiomyopathy.
    Vakil RM; Marine JE; Kolandaivelu A; Dickfeld T; Weiss RG; Tomaselli GF; Chrispin J; Wu KC
    JACC Clin Electrophysiol; 2022 Aug; 8(8):957-966. PubMed ID: 35981800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder.
    Gharbin J; Winful A; Hassan MA; Bajaj S; Batta Y; Alebna P; Rhodd S; Taha M; Fatima U; Mehrotra P
    Curr Probl Cardiol; 2023 May; 48(5):101609. PubMed ID: 36690309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathy.
    Hammersley DJ; Jones RE; Owen R; Mach L; Lota AS; Khalique Z; De Marvao A; Androulakis E; Hatipoglu S; Gulati A; Reddy RK; Yoon WY; Talukder S; Shah R; Baruah R; Guha K; Pantazis A; Baksi AJ; Gregson J; Cleland JGF; Tayal U; Pennell DJ; Ware JS; Halliday BP; Prasad SK
    Eur J Heart Fail; 2023 Nov; 25(11):2050-2059. PubMed ID: 37728026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy.
    Kim EK; Chang SA; Choi JO; Glockner J; Shapiro B; Choe YH; Fine N; Jang SY; Kim SM; Miller W; Lee SC; Oh JK
    Korean Circ J; 2016 Jan; 46(1):41-7. PubMed ID: 26798384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular free wall strain in acutely decompensated heart failure patients with ischemic and non-ischemic cardiomyopathy.
    Miric D; Barac A; Capkun V; Bakovic D
    Echocardiography; 2021 Oct; 38(10):1747-1753. PubMed ID: 34555211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
    Middour TG; Rosenthal TM; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Bober RM; Morin DP
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1137-1146. PubMed ID: 32064730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating Nonischemic Dilated Cardiomyopathy With Incidental Infarction From Ischemic Cardiomyopathy by Geometric Indices Derived From Cardiovascular Magnetic Resonance.
    Wang X; Costello BT; Papapostolou S; O'Brien J; Taylor A; Zhao S
    J Thorac Imaging; 2021 Jul; 36(4):248-253. PubMed ID: 32960835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative regional left ventricular wall thickening determined by quantitative gated SPECT as a predictor of mid-term surgical results for ischemic and nonischemic cardiomyopathy.
    Kubota S; Wakasa S; Shingu Y; Ooka T; Tachibana T; Matsui Y
    Circ J; 2013; 77(12):2936-41. PubMed ID: 23995760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress variables add differential diagnostic information between ischemic and nonischemic cardiomyopathy over myocardial perfusion SPECT imaging.
    Romero-Farina G; Aguadé-Bruix S; Candell-Riera J; Castell-Conesa J; Fernández-Sálguero R; García-Dorado D
    Nucl Med Commun; 2013 Feb; 34(2):117-23. PubMed ID: 23211995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.